20 hrs ago | BioSpace
Janssen Therapeutics Release: FDA Issues Complete Response Letter for ...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has issued a Complete Response letter for a ... (more)
Gilead Files European Marketing Application for Boosting Agent Cobicistat
FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. announced today that the Marketing Authorisation Application for cobicistat, submitted on April 26, 2012, has been validated by the European Medicines Agency .
Gilead Quad Tablet Gets FDA Committee Approval Nod
Federal Judge Upholds 50-Year Sentence for Iowa Man With HIV Engineering CD8 Cells to Kill HIV in Tissues A Piece of Me The Voice of a Generation Report Outlines HIV Cure Research, Important Gaps Gene-Modified T Cells Persist for a Decade, Without Major Risks .
Understanding Polymer Properties Important for Crystal Growth...
The use of supersaturating dosage forms, such amorphous dispersions, is an increasingly common approach for improving delivery of poorly water-soluble drugs.
Canadian cohort shows viral suppression most likely with...
HIV treatment is not a cure, but it is keeping millions of people well. Start learning about it in this section.
Also on Topix